| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,088,600 ) |
| | 2025 | 2025 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 000 | 4 | NIH | 12/16/2024 | $448,906 |
| | 2025 | 2025 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 000 | 6 | NIH | 12/10/2024 | $556,250 |
| | 2025 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 003 | 4 | NIH | 1/15/2025 | $27,560 |
| | 2025 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 003 | 4 | NIH | 1/15/2025 | $55,883 |
|
| Issue Date FY: 2024 ( Subtotal = $7,604,871 ) |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 000 | 5 | NIH | 1/3/2024 | $575,675 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U42GM115336 | The NIGMS Human Genetic Cell Repository | 001 | 10 | NIH | 6/19/2024 | $162,264 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U42GM115336 | The NIGMS Human Genetic Cell Repository | 000 | 10 | NIH | 2/27/2024 | $1,460,377 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R21HL175169 | Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists | 000 | 1 | NIH | 9/6/2024 | $146,876 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U24HG008736 | NHGRI Sample Repository for Human Genetic Research | 000 | 9 | NIH | 6/24/2024 | $884,735 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 001 | 3 | NIH | 6/12/2024 | $39,903 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 000 | 3 | NIH | 1/4/2024 | $448,906 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA269685 | Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma | 001 | 3 | NIH | 8/9/2024 | $420,169 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01AA030026 | NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology | 000 | 4 | NIH | 7/19/2024 | $589,786 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | P50CA254897 | Epigenetic Therapies - New Approaches | 000 | 4 | NIH | 7/16/2024 | $2,421,039 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA255221 | Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML | 001 | 4 | NIH | 4/18/2024 | $20,414 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA255221 | Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML | 000 | 4 | NIH | 2/22/2024 | $367,449 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 004 | 5 | NIH | 4/16/2024 | $8,091 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 003 | 5 | NIH | 4/16/2024 | $31,300 |
| | 2024 | 2024 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 002 | 5 | NIH | 2/15/2024 | $146,495 |
| | 2024 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA269685 | Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma | 000 | 2 | NIH | 3/13/2024 | $0 |
| | 2024 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA214005 | Role of the microbiota in DNA methylation and CRC development | 000 | 6 | NIH | 4/10/2024 | -$151,935 |
| | 2024 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 001 | 4 | NIH | 1/18/2024 | $33,327 |
|
| Issue Date FY: 2023 ( Subtotal = $8,094,463 ) |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 001 | 2 | NIH | 3/10/2023 | $51,194 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01AA030026 | NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology | 002 | 3 | NIH | 7/25/2023 | $616,892 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA269685 | Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma | 001 | 2 | NIH | 9/20/2023 | $452,423 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 000 | 2 | NIH | 12/27/2022 | $460,745 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | P50CA254897 | Epigenetic Therapies - New Approaches | 001 | 3 | NIH | 7/12/2023 | $2,345,381 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U24HG008736 | NHGRI Sample Repository for Human Genetic Research | 000 | 8 | NIH | 5/18/2023 | $923,080 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA255221 | Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML | 000 | 3 | NIH | 2/23/2023 | $400,445 |
| | 2023 | 2023 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U42GM115336 | The NIGMS Human Genetic Cell Repository | 000 | 9 | NIH | 2/14/2023 | $1,825,714 |
| | 2023 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 001 | 4 | NIH | 8/1/2023 | $364,093 |
| | 2023 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA244236 | Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma | 003 | 4 | NIH | 8/21/2023 | $81,195 |
| | 2023 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | P50CA254897 | Epigenetic Therapies - New Approaches | 000 | 2 | NIH | 12/2/2022 | $0 |
| | 2023 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH INC | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01AA030026 | NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology | 001 | 2 | NIH | 5/12/2023 | $573,301 |
|
| Issue Date FY: 2022 ( Subtotal = $6,609,489 ) (Continued on the next page) |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U42GM115336 | The NIGMS Human Genetic Cell Repository | 000 | 8 | NIH | 2/14/2022 | $1,642,920 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U42GM115336 | The NIGMS Human Genetic Cell Repository | 001 | 8 | NIH | 5/23/2022 | $182,550 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA214005 | Role of the microbiota in DNA methylation and CRC development | 000 | 6 | NIH | 11/15/2021 | $524,319 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA214005 | Role of the microbiota in DNA methylation and CRC development | 001 | 6 | NIH | 4/28/2022 | $46,607 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA255221 | Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML | 000 | 2 | NIH | 3/9/2022 | $367,755 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01CA255221 | Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML | 001 | 2 | NIH | 5/3/2022 | $32,690 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | P50CA254897 | Epigenetic Therapies - New Approaches | 001 | 2 | NIH | 9/21/2022 | $50,437 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | P50CA254897 | Epigenetic Therapies - New Approaches | 000 | 2 | NIH | 9/1/2022 | $2,294,944 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 001 | 1 | NIH | 1/14/2022 | $0 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | R01HL157118 | The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | 000 | 1 | NIH | 12/31/2021 | $524,381 |
| | 2022 | 2022 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U24HG008736 | NHGRI Sample Repository for Human Genetic Research | 002 | 7 | NIH | 5/27/2022 | $942,886 |
| | 2022 | 2021 | CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | 403 HADDON AVE | CAMDEN | NJ | 08103-1505 | CAMDEN | USA | U24HG008736 | NHGRI Sample Repository for Human Genetic Research | 001 | 6 | NIH | 3/2/2022 | $0 |
|
